AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12439628 — intervention group
Group type: EXPERIMENTAL
Intervention: High TRP/LNAA values
Number of subjects: 104
Study 11071049 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (Sal, 6 mg)
Number of subjects: 9
Study 11071049 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 9
Study 8694013 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified breast milk with multinutrient fortifier (mean duration 39 days)
Number of subjects: 275
Study 8694013 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified breast milk
Number of subjects: 275
Study 8694013 — intervention group
Group type: COMPARATOR
Intervention: Control supplement containing phosphate and vitamins
Number of subjects: 275
Study 1304482 — intervention group
Group type: EXPERIMENTAL
Intervention: Single carboplatin (cp) at the dose of 260‐410 mg/m2
Number of subjects: 53
Study 1304482 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy of carboplatin (cp) at a dose of 180‐350 mg/m2 plus adriamycin and cyclophosphamide
Number of subjects: 53
Study 1304482 — intervention group
Group type: EXPERIMENTAL
Intervention: Single carboplatin (cp)
Number of subjects: 53
Study 1304482 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy of carboplatin (cp) plus adriamycin and cyclophosphamide
Number of subjects: 53
Study 1304482 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (cp)
Number of subjects: 53
Study 3534333 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (mevinolin) 40 mg twice a day
Number of subjects: 101
Study 3534333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 31189408 — intervention group
Group type: EXPERIMENTAL
Intervention: Supernatural afterlife-confirmed prime
Number of subjects: 742
Study 31189408 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural (medical indefinite life extension; MILE) immortality prime
Number of subjects: 742
Study 31189408 — intervention group
Group type: COMPARATOR
Intervention: Mortality Salience (MS) prime
Number of subjects: 742
Study 30172864 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine Butylbromide (HB) administered once DR occurs (Group 1)
Number of subjects: 132
Study 30172864 — intervention group
Group type: COMPARATOR
Intervention: Hyoscine Butylbromide (HB) given prophylactically (Group 2)
Number of subjects: 132
Study 26614176 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 59
Study 26614176 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaglobin(®)
Number of subjects: 59
Study 25348244 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP treatment
Number of subjects: 156
Study 25348244 — intervention group
Group type: COMPARATOR
Intervention: CPAP treatment
Number of subjects: 156
Study 22048129 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 mg transdermal nicotine
Number of subjects: 29
Study 22048129 — intervention group
Group type: EXPERIMENTAL
Intervention: 21 mg transdermal nicotine
Number of subjects: 29
Study 22048129 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 29
Study 20346217 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined temperature- and power-controlled RFA
Number of subjects: 55
Study 20346217 — intervention group
Group type: COMPARATOR
Intervention: Power-controlled RFA
Number of subjects: 55
Study 18615988 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise excavation over 2 visits
Number of subjects: 0
Study 18615988 — intervention group
Group type: COMPARATOR
Intervention: Complete excavation of deep caries
Number of subjects: 0
Study 19664296 — intervention group
Group type: EXPERIMENTAL
Intervention: Trehalose (75 g carbohydrate equivalents)
Number of subjects: 10
Study 19664296 — intervention group
Group type: COMPARATOR
Intervention: Glucose (75 g carbohydrate equivalents)
Number of subjects: 10
Study 15020035 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental agent (exact agent not specified)
Number of subjects: 0
Study 15020035 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 11686541 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldosterone (0.5 mg) during normoxia (FiO2=0.21)
Number of subjects: 9
Study 11686541 — intervention group
Group type: COMPARATOR
Intervention: Placebo during normoxia (FiO2=0.21)
Number of subjects: 9
Study 9457566 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapeziectomy alone
Number of subjects: 76
Study 9457566 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapeziectomy with tendon interposition
Number of subjects: 76
Study 9457566 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapeziectomy with ligament reconstruction
Number of subjects: 76
Study 9457566 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 76
Study 8186174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 215
Study 8186174 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron plus placebo
Number of subjects: 215
Study 3285877 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 434
Study 3285877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study 30817416 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone nursing
Number of subjects: 500
Study 30817416 — intervention group
Group type: EXPERIMENTAL
Intervention: Calmness of the nurse during the call
Number of subjects: 500
Study 30817416 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarity of advice given
Number of subjects: 500
Study 30817416 — intervention group
Group type: EXPERIMENTAL
Intervention: Competence of the nurse
Number of subjects: 500
Study 31496531 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial rebreathing mask (PRM)
Number of subjects: 88
Study 31496531 — intervention group
Group type: COMPARATOR
Intervention: Hudson's mask
Number of subjects: 88
Study 28800842 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D prediction technique
Number of subjects: 57
Study 28800842 — intervention group
Group type: COMPARATOR
Intervention: 2D prediction technique
Number of subjects: 57
Study 26311179 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual protocol
Number of subjects: 13
Study 26311179 — intervention group
Group type: COMPARATOR
Intervention: Abrupt protocol
Number of subjects: 13
Study 24280575 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 60
Study 24280575 — intervention group
Group type: COMPARATOR
Intervention: Placebo control acupuncture
Number of subjects: 60
Study 20665468 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke specific Geriatric Depression Scale (SS‐GDS)
Number of subjects: 91
Study 20665468 — intervention group
Group type: EXPERIMENTAL
Intervention: SS‐GDS
Number of subjects: 91
Study 20186638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention based on self-determination theory
Number of subjects: 215
Study 20186638 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 215
Study 17663307 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin receptor antagonists
Number of subjects: 0
Study 15313942 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Ventricular Assist Device (LVAD)
Number of subjects: 91
Study 15313942 — intervention group
Group type: COMPARATOR
Intervention: Optimal Medical Management (OMM)
Number of subjects: 91
Study 11706714 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlogenzym (3 times 3 tablets for the first three days, then 3 times 2 tablets)
Number of subjects: 60
Study 11706714 — intervention group
Group type: COMPARATOR
Intervention: Standard antioedematous drugs based on aescin (control group)
Number of subjects: 60
Study 11706714 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlogenzym
Number of subjects: 60
Study 9536580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ames reagent strip
Number of subjects: 100
Study 9536580 — intervention group
Group type: EXPERIMENTAL
Intervention: Boehringer reagent strip
Number of subjects: 100
Study 8201151 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy
Number of subjects: 400
Study 8201151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 3295590 — intervention group
Group type: EXPERIMENTAL
Intervention: Progabide (PGB)
Number of subjects: 0
Study 3295590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28967441 — intervention group
Group type: EXPERIMENTAL
Intervention: 20h of visual processing training plus cognitive remediation
Number of subjects: 20
Study 28967441 — intervention group
Group type: COMPARATOR
Intervention: 20h of computer‐assisted cognitive remediation alone
Number of subjects: 20
Study 26892534 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Chamber (SC) settings
Number of subjects: 0
Study 26892534 — intervention group
Group type: COMPARATOR
Intervention: Dual Chamber (DC) settings
Number of subjects: 0
Study 24295879 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted, practice-directed intervention
Number of subjects: 0
Study 24295879 — intervention group
Group type: COMPARATOR
Intervention: Standard dissemination
Number of subjects: 0
Study 23285646 — intervention group
Group type: EXPERIMENTAL
Intervention: Block-like sutures and radiofrequency coagulation
Number of subjects: 90
Study 23285646 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic, jet-like dissection, or clamp crushing methods
Number of subjects: 90
Study 20346025 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser
Number of subjects: 20
Study 20346025 — intervention group
Group type: COMPARATOR
Intervention: 308-nm excimer lamp
Number of subjects: 20
Study 18538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS)
Number of subjects: 13
Study 18538648 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 13
Study 15944532 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine myocardial perfusion imaging (MPI)
Number of subjects: 126
Study 12528584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led clinic in schools
Number of subjects: 0
Study 12528584 — intervention group
Group type: COMPARATOR
Intervention: General practice care
Number of subjects: 0
Study 9706373 — intervention group
Group type: EXPERIMENTAL
Intervention: New slow-release tablet formulation (Pindac)
Number of subjects: 18
Study 9706373 — intervention group
Group type: COMPARATOR
Intervention: Standard slow-release capsule formulation
Number of subjects: 18
Study 7644775 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (100 micrograms b.d.)
Number of subjects: 24
Study 7644775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2766522 — intervention group
Group type: EXPERIMENTAL
Intervention: St. Jude Medical prosthetic heart valves
Number of subjects: 90
Study 2766522 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic Hall prosthetic heart valves
Number of subjects: 90
Study 2766522 — intervention group
Group type: COMPARATOR
Intervention: St. Jude Medical aortic prostheses
Number of subjects: 90
Study 2766522 — intervention group
Group type: COMPARATOR
Intervention: Medtronic Hall aortic prostheses
Number of subjects: 90
Study 2766522 — intervention group
Group type: COMPARATOR
Intervention: St. Jude Medical mitral prostheses
Number of subjects: 90
Study 2766522 — intervention group
Group type: COMPARATOR
Intervention: Medtronic Hall mitral prostheses
Number of subjects: 90
Study 238412 — intervention group
Group type: EXPERIMENTAL
Intervention: AH 8165
Number of subjects: 0
Study 29488461 — intervention group
Group type: EXPERIMENTAL
Intervention: Household WASH package (chlorine, soap, water storage container, and promotion on its use)
Number of subjects: 1603
Study 29488461 — intervention group
Group type: COMPARATOR
Intervention: Control (OTP only)
Number of subjects: 1603
Study 27627817 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg aspirin before surgery and 100 mg daily for up to 30 days after surgery
Number of subjects: 10010
Study 27627817 — intervention group
Group type: COMPARATOR
Intervention: Placebo before surgery and placebo daily for up to 30 days after surgery
Number of subjects: 10010
Study 27627817 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (pooled analysis)
Number of subjects: 10010
Study 27627817 — intervention group
Group type: COMPARATOR
Intervention: Placebo (pooled analysis)
Number of subjects: 10010
Study 24478190 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 270 mg iodine pro ml
Number of subjects: 148
Study 24478190 — intervention group
Group type: COMPARATOR
Intervention: Ioversol 320 mg iodine pro ml
Number of subjects: 148
Study 22095021 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention
Number of subjects: 447
Study 22095021 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 447
Study 20401355 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate (1.0 mol/L) injection
Number of subjects: 52
Study 20401355 — intervention group
Group type: COMPARATOR
Intervention: Co-injection of NMDA antagonist ketamine (10 mmol/L)
Number of subjects: 52
Study 18703787 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of life-sustaining interventions taking more than 1 day
Number of subjects: 584
Study 18703787 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation before death
Number of subjects: 584
Study 15903363 — intervention group
Group type: EXPERIMENTAL
Intervention: Open‐stance cycling protocol (OSCP)
Number of subjects: 40
Study 15903363 — intervention group
Group type: COMPARATOR
Intervention: Traditional cycling foot position (TCFP)
Number of subjects: 40
Study 12621274 — intervention group
Group type: EXPERIMENTAL
Intervention: End-tidal CO2 monitoring
Number of subjects: 40
Study 11711256 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin oral suspension, 10 mg/kg once daily for 3 days
Number of subjects: 2425
Study 9174835 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutathione (GSH) levels in plasma
Number of subjects: 0
Study 9174835 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutathione disulfide (GSSG) levels in plasma
Number of subjects: 0
Study 9174835 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH/GSSG ratio
Number of subjects: 0
Study 1634055 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI technique for measuring gastric emptying using a liquid meal containing Gadolinium tetraazacyclododecane tetraacetic acid as a marker.
Number of subjects: 10
Study 1634055 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI technique for measuring total gastric volumes and gastric secretory rates.
Number of subjects: 10
Study 1634055 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI method for reflecting gastric emptying disorders in patients.
Number of subjects: 10
Study 3980239 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program for family members including counseling and a booklet on supporting medication compliance, appointment keeping, diet, and weight control.
Number of subjects: 0
Study 3980239 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 30880271 — intervention group
Group type: EXPERIMENTAL
Intervention: First arm: 59.5 Gy to the gross tumor volume and 47.6 Gy to the remaining larynx, delivered in 17 fractions.
Number of subjects: 13
Study 30880271 — intervention group
Group type: COMPARATOR
Intervention: Second arm: 55 Gy to the gross tumor volume and 40.7 Gy to the remaining larynx, delivered in 11 fractions.
Number of subjects: 13
Study 28834086 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated IL-6 (third tertile vs first tertile)
Number of subjects: 1485
Study 28834086 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined elevated levels of CRP and IL-6 (both markers ≥75th percentile vs <75th percentile)
Number of subjects: 1485
Study 28834086 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined elevated levels of CRP and fibrinogen (both markers ≥75th percentile vs <75th percentile)
Number of subjects: 1485
Study 27958622 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous ampicillin every 6 hours
Number of subjects: 148
Study 27958622 — intervention group
Group type: COMPARATOR
Intervention: 2 g of intravenous ampicillin every 6 hours
Number of subjects: 148
Study 25219200 — intervention group
Group type: EXPERIMENTAL
Intervention: Rush immunotherapy (RIT)
Number of subjects: 87
Study 25219200 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunotherapy
Number of subjects: 87
Study 22185492 — intervention group
Group type: EXPERIMENTAL
Intervention: Distractor condition with orientation changes preceding the cue
Number of subjects: 13
Study 22185492 — intervention group
Group type: COMPARATOR
Intervention: Control condition with coherent motion of the bars
Number of subjects: 13
Study 20207497 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiation (70.2 GyE)
Number of subjects: 64
Study 20207497 — intervention group
Group type: COMPARATOR
Intervention: High-dose radiation (79.2 GyE)
Number of subjects: 64
Study 20207497 — intervention group
Group type: EXPERIMENTAL
Intervention: DVH parameters (V60 > 54%, V70 > 44%, V75 > 39%)
Number of subjects: 64
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of three drugs from two different classes (2 nucleosides or nucleotide analogs (NRTI) plus 1 non‐nucleoside (NNRTI) or 1 boosted protease inhibitor (PI/r))
Number of subjects: 0
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of ART in patients with CD4+ counts of < 200 cells/microl
Number of subjects: 0
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of ART in most patients with CD4+ counts of 200‐350 cells/microl
Number of subjects: 0
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay of therapy in patients with CD4+ counts of > 350 cells/microl
Number of subjects: 0
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to therapy
Number of subjects: 0
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype studies
Number of subjects: 0
Study 17261244 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized approach to therapy
Number of subjects: 0
Study 15677775 — intervention group
Group type: EXPERIMENTAL
Intervention: glargine plus OAD
Number of subjects: 371
Study 15677775 — intervention group
Group type: COMPARATOR
Intervention: 70/30
Number of subjects: 371
Study 11517136 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 10
Study 11517136 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic Positive Airway Pressure (BIPAP)
Number of subjects: 10
Study 11517136 — intervention group
Group type: COMPARATOR
Intervention: Control (volume-controlled mechanical ventilation)
Number of subjects: 10
Study 9491833 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal oestradiol (50 microg daily)
Number of subjects: 62
Study 9491833 — intervention group
Group type: COMPARATOR
Intervention: Transdermal oestradiol (50 microg daily) and medroxyprogesterone acetate (10 mg daily for the first 12 days of each month)
Number of subjects: 62
Study 7942414 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 0
Study 7942414 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant drugs
Number of subjects: 0
Study 7942414 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 0
Study 7942414 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-current cardioversion
Number of subjects: 0
Study 2906118 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP regimen
Number of subjects: 199
Study 2906118 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil plus prednisone
Number of subjects: 199
Study 2066755 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclophosphamide-doxorubicin
Number of subjects: 298
Study 2066755 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin-teniposide and cyclophosphamide-doxorubicin
Number of subjects: 298
Study 2066755 — intervention group
Group type: EXPERIMENTAL
Intervention: N-myc gene amplification
Number of subjects: 298
Study 2066755 — intervention group
Group type: EXPERIMENTAL
Intervention: tumor cell ploidy and N-myc gene copy number
Number of subjects: 298
Study 794661 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (100 mug)
Number of subjects: 23
Study 794661 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline (250 mg)
Number of subjects: 23
Study 31597907 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control strategy
Number of subjects: 2513
Study 31597907 — intervention group
Group type: COMPARATOR
Intervention: Rate control strategy
Number of subjects: 2513
Study 31989155 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose DCB (In.Pact™)
Number of subjects: 414
Study 31989155 — intervention group
Group type: COMPARATOR
Intervention: Low-dose DCB (Ranger™)
Number of subjects: 414
Study 31043185 — intervention group
Group type: EXPERIMENTAL
Intervention: Combat Stress Inoculation (CSI) group
Number of subjects: 305
Study 31043185 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard educational program)
Number of subjects: 305
Study 31043185 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CSI and Control)
Number of subjects: 305
Study 28835366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 245
Study 25640628 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus standard-dose cisplatin and 5-fluorouracil (SDPF) chemotherapy (arm A)
Number of subjects: 142
Study 25640628 — intervention group
Group type: COMPARATOR
Intervention: RT plus low-dose cisplatin and 5-fluorouracil (LDPF) chemotherapy (arm B)
Number of subjects: 142
Study 23642047 — intervention group
Group type: COMPARATOR
Intervention: Oxygen saturation target of 85 to 89%
Number of subjects: 2448
Study 22009765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue electrical properties measurements using tiny surface electrodes in four-electrode configuration
Number of subjects: 15
Study 20108073 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric low-glycemic index diet
Number of subjects: 26
Study 20108073 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric high-glycemic index diet
Number of subjects: 26
Study 20108073 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 26